Earnings Call · Q2 FY2021·2021-08-08

Q2 21EPS +23.08%·Rev n/aQ1 21EPS -16.67%·Rev n/aQ4 20EPS n/a·Rev n/aQ4 19EPS n/a·Rev n/a⚠ consensus missing

TREACE MEDICAL CONCEPTS, INC. TMCI

Vivian Cervantes — Investor Relations or Communications

John Treace — Chief Executive Officer

Mark Hair — Chief Financial Officer

0.0%1d on move date−0.6% vs SPY3d−6.9%5d−7.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TMCI calls or request research access.

More TMCI calls Browse calls Request research access